These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 35913655)

  • 1. Practical Guidance on Open Source and Commercial Automated Insulin Delivery Systems: A Guide for Healthcare Professionals Supporting People with Insulin-Requiring Diabetes.
    Lewis DM; Hussain S
    Diabetes Ther; 2022 Sep; 13(9):1683-1699. PubMed ID: 35913655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of British Clinical Diabetologists, Diabetes Technology Network UK and Association of Children's Diabetes Clinicians Survey of UK Healthcare Professional Attitudes Towards Open-Source Automated Insulin Delivery Systems.
    Crabtree TSJ; Choudhary P; Lumb A; Hammond P; McLay A; Campbell F; Ng SM; Wilmot EG; Hussain S
    Diabetes Ther; 2022 Feb; 13(2):341-353. PubMed ID: 35099784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Why #WeAreNotWaiting-Motivations and Self-Reported Outcomes Among Users of Open-source Automated Insulin Delivery Systems: Multinational Survey.
    Braune K; Gajewska KA; Thieffry A; Lewis DM; Froment T; O'Donnell S; Speight J; Hendrieckx C; Schipp J; Skinner T; Langstrup H; Tappe A; Raile K; Cleal B
    J Med Internet Res; 2021 Jun; 23(6):e25409. PubMed ID: 34096874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leveraging advances in diabetes technologies in primary care: a narrative review.
    Bode B; King A; Russell-Jones D; Billings LK
    Ann Med; 2021 Dec; 53(1):805-816. PubMed ID: 34184589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Barriers to Uptake of Open-Source Automated Insulin Delivery Systems: Analysis of Socioeconomic Factors and Perceived Challenges of Caregivers of Children and Adolescents With Type 1 Diabetes From the OPEN Survey.
    Huhndt A; Chen Y; O'Donnell S; Cooper D; Ballhausen H; Gajewska KA; Froment T; Wäldchen M; Lewis DM; Raile K; Skinner TC; Braune K
    Front Clin Diabetes Healthc; 2022; 3():876511. PubMed ID: 36992765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Learning challenges of healthcare professionals supporting open-source automated insulin delivery.
    Crocket H; Lewis DM; Burnside M; Faherty A; Wheeler B; Frewen C; Lever C; Jefferies C; Williman J; Sanders O; Wilson R; Paul R; Price S; Jones S; de Bock M
    Diabet Med; 2022 May; 39(5):e14750. PubMed ID: 34826158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Point-Counterpoint: The Need for Do-It-Yourself (DIY) Open Source (OS) AID Systems in Type 1 Diabetes Management.
    Forlenza GP; Tabatabai I; Lewis DM
    Diabetes Technol Ther; 2024 May; ():. PubMed ID: 38669472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do-It-Yourself and Commercial Automated Insulin Delivery Systems in Type 1 Diabetes: An Uncertain Area for Canadian Health-care Providers.
    Morrison AE; Senior PA; Bubela T; Farnsworth K; Witteman HO; Lam A
    Can J Diabetes; 2022 Dec; 46(8):863-870. PubMed ID: 35945126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real-world evidence on clinical outcomes of people with type 1 diabetes using open-source and commercial automated insulin dosing systems: A systematic review.
    Knoll C; Peacock S; Wäldchen M; Cooper D; Aulakh SK; Raile K; Hussain S; Braune K
    Diabet Med; 2022 May; 39(5):e14741. PubMed ID: 34773301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Do-It-Yourself Artificial Pancreas: A Comprehensive Review.
    Kesavadev J; Srinivasan S; Saboo B; Krishna B M; Krishnan G
    Diabetes Ther; 2020 Jun; 11(6):1217-1235. PubMed ID: 32356245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Practical Guidance for Healthcare Providers on Collaborating with People with Type 2 Diabetes: Advancing Treatment and Initiating Injectable Therapy.
    Boeder S; Matamoros D; Mansy C
    Diabetes Ther; 2023 Feb; 14(2):425-446. PubMed ID: 36520406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Large-Scale Data Analysis for Glucose Variability Outcomes with Open-Source Automated Insulin Delivery Systems.
    Shahid A; Lewis DM
    Nutrients; 2022 May; 14(9):. PubMed ID: 35565875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CREATE (Community deRivEd AutomaTEd insulin delivery) trial. Randomised parallel arm open label clinical trial comparing automated insulin delivery using a mobile controller (AnyDANA-loop) with an open-source algorithm with sensor augmented pump therapy in type 1 diabetes.
    Burnside M; Lewis D; Crocket H; Wilson R; Williman J; Jefferies C; Paul R; Wheeler BJ; de Bock M
    J Diabetes Metab Disord; 2020 Dec; 19(2):1615-1629. PubMed ID: 32837953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emotional and Physical Health Impact in Children and Adolescents and Their Caregivers Using Open-source Automated Insulin Delivery: Qualitative Analysis of Lived Experiences.
    Braune K; Krug N; Knoll C; Ballhausen H; Thieffry A; Chen Y; O'Donnell S; Raile K; Cleal B
    J Med Internet Res; 2022 Jul; 24(7):e37120. PubMed ID: 35834298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Qualitative Study of User Experiences with Loop, an Open-Source Automated Insulin Delivery System.
    Suttiratana SC; Wong JJ; Lanning MS; Dunlap A; Hanes SJ; Hood KK; Lal RA; Naranjo D
    Diabetes Technol Ther; 2022 Jun; 24(6):416-423. PubMed ID: 35099278
    [No Abstract]   [Full Text] [Related]  

  • 16. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Removing Barriers, Bridging the Gap, and the Changing Role of the Health Care Professional with Automated Insulin Delivery Systems.
    Lingen K; Maahs D; Bellini N; Isaacs D
    Diabetes Technol Ther; 2024 Mar; 26(S3):45-52. PubMed ID: 38377318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review of Automated Insulin Delivery Systems for Type 1 Diabetes and Associated Time in Range Outcomes.
    Nallicheri A; Mahoney KM; Gutow HA; Bellini N; Isaacs D
    touchREV Endocrinol; 2022 Jun; 18(1):27-34. PubMed ID: 35949359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perioperative Care of Patients Using Wearable Diabetes Devices.
    Cruz P; McKee AM; Chiang HH; McGill JB; Hirsch IB; Ringenberg K; Wildes TS
    Anesth Analg; 2024 Jun; ():. PubMed ID: 38913575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrospective Comparison of Commercially Available Automated Insulin Delivery With Open-Source Automated Insulin Delivery Systems in Type 1 Diabetes.
    Schütz A; Rami-Merhar B; Schütz-Fuhrmann I; Blauensteiner N; Baumann P; Pöttler T; Mader JK
    J Diabetes Sci Technol; 2024 Feb; ():19322968241230106. PubMed ID: 38366626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.